PMTCT Intervention Domain | Items on knowledge assessment tool | Respondents’ response | |
---|---|---|---|
Correct (%) | Incorrect (%) | ||
Provision of integrated PMTCT services within routine prenatal care | The PMTCT guidelines recommend: a). Group counselling and Opt-in HIV testing b). Individual counselling and opt-out testing c). Group counselling and opt-out testing | 4 (3.5) | 109 (96.5) |
Screening of HIV at the “Booking clinic’ is the entry into PMTCT services | 109 (96.5) | 4 (3.5) | |
Screening of all pregnant women at their first prenatal clinic for HIV infection | Posttest counselling of HIV-negative women is not required | 193 (82.3) | 20 (17.7) |
Screening of all HIV positive pregnant women for co-morbid opportunistic infections like Tuberculosis | You should check the blood levels (PCV) of a pregnant HIV positive woman: a). at the booking clinic and every other clinic b). at the booking clinic and 3 other clinics c). at the booking clinic and whenever it is necessary | 42 (37.8) | 71 (62.8) |
HIV viral load in pregnancy should be checked: a). At the booking clinic only b). At the booking clinic and 34–36 weeks’ gestation c). At the booking visit, 34–36 weeks’ gestation and in labour | 60 (53.1) | 53 (46.9) | |
Provision of posttest counselling to all women and link all HIV-positive women to ART initiation | Select the wrong sentence from below: a). HIV medications once started in pregnancy should be used for life. b). The preferred medication is (Tenofovir/Lamivudine/Efavirenz) known as Telura® c). Not all HIV positive pregnant women need to take HIV medications | 78 (69) | 33 (29.2) |
Performance of repeat HIV screening for HIV-negative women late in pregnancy and intrapartum. | A woman who had an HIV-negative test result at 24 weeks should have a repeat HIV test at 34–38 weeks’ gestation | 91 (80.5) | 22 (19.5) |
A woman who had an HIV-negative test result at 18 weeks should have a repeat HIV test at 34–38 weeks’ gestation | 90 (79.6) | 23 (20.4) | |
Intrapartum interventions | Artificial rupture of fetal membranes (ARM) should be performed in labour when the cervix is ≥7 cm dilated | 43 (38.0) | 70 (62.0) |
Episiotomy (surgical perineal cut) should be given to make HIV positive women deliver quicker. | 96 (85.0) | 17 (15.0) | |
Commencement of ART infant prophylaxis to all HIV-exposed infants within 72 hours of birth | All HIV-exposed infants should have Nevirapine syrup daily soon after birth, within 72 hours. | 109 (96.5) | 2 (1.8) |
A high-risk HIV-exposed infant has a mother: a. Who used ART for more than 4 weeks at the time of birth. b. Who has a viral load > 1000 copies/ml 4 weeks before birth. c. All of the above | 60 (53.1) | 52 (46.0) | |
Maternal postpartum care | Discussion of postpartum family planning should start at the postnatal clinic. | 43 (38.0) | 70 (62.0) |
Childhood immunization for the HIV-exposed infant | HIV-exposed infants should not be given the second dose of the Oral Polio vaccine at 6 weeks old. | 104 (92.0) | 9 (8) |
Early infant HIV diagnosis (EID) | Dry blood sample (DBS) test (DNA PCR) is done at 6–8 weeks of life for HIV-exposed infant | 100 (88.5) | 12 (10.6) |
Opportunistic infection prophylaxis | Cotrimoxazole (Septrin®) prophylaxis for all HIV-exposed infants at 6 weeks is not necessary. | 82 (72.6) | 31 (27.4) |